Agios Pharmaceuticals | Koszty Sprzedaży



Cost Of Sales Zmiana Data
AbbVie USD 4B 394M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amgen USD 2.6B 507M 2025-03
Astellas Pharma JPY 76.86B 21.67B 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.62B 98M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Daiichi Sankyo JPY 94.34B 34.04B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Exelixis USD 19.17M 793K 2025-04
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Agios Pharmaceuticals Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.